NewLink Genetics (NLNK) Tops Q3 EPS by 6c

NewLink Genetics (NASDAQ: NLNK) reported Q3 EPS of ($0.54), $0.06 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $15.35 million versus the consensus estimate of $3.83 million.

For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.

You May Also Be Interested In

• Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
• Union Pacific (UNP) Tops Q1 EPS by 18c
• Esquire Financial Holdings, Inc. (ESQ) Tops Q1 EPS by 3c